<DOC>
	<DOCNO>NCT01571908</DOCNO>
	<brief_summary>Magnesium accelerate reaction rocuronium , neuromuscular blocker use muscle relaxation ease intubation anaesthesia . Succinylcholine fast react neuromuscular blocker . It often use emergency procedure , rapid intubation necessary . We want perfusion magnesium anaesthesia accelerate extent reaction rocuronium intubation condition comparable even good succinylcholine alone ( prior perfusion saline=placebo )</brief_summary>
	<brief_title>Rapid Sequence Intubation With Magnesium-rocuronium Compared With Succinylcholine - A Randomised Clinical Study</brief_title>
	<detailed_description>Rapid sequence intubation ( RSI ) prefer method endotracheal intubation emergency set . The aim RSI achieve rapid unconsciousness complete neuromuscular blockade facilitates endotracheal intubation . RSI particular importance unfasten patient risk regurgitation subsequent aspiration stomach content lungs induction anaesthesia . Still today , succinylcholine neuromuscular block agent choice RSI . However , unfortunately 60 80 % intubation condition excellent contraindication usage succinylcholine numerous side effect . Thus need alternative technique allow rapid , high-quality safe intubation condition . Magnesium impact neuromuscular transmission ; reduces amount acetylcholine release motor nerve terminal . It show IV infusion magnesium sulphate prior standard intubation dose rocuronium enhance speed onset neuromuscular block compare rocuronium alone 35 % much less variability onset time . This make combination magnesium-rocuronium potentially interesting alternative succinylcholine RSI . The investigator objective compare surgical patient standardize RSI procedure intubation condition rocuronium 0.6 mg kg-1 pre-treatment intravenous MgSO4 60 mg kg-1 ( experimental intervention ) succinylcholine 1 mg kg-1 ( control intervention ) quantify minor major adverse event . The investigator primary hypothesis rocuronium 0.6 mg kg-1 , pre-treatment MgSO4 60 mg kg-1 , rate excellent intubation condition high ( 80 % ) compare succinylcholine 1 mg kg-1 ( 60 % ) . This two centre ( Division Anaesthesiology , Geneva University Hospitals Division Anaesthesiology , University Hospital Lausanne ) , stratify ( male , female ) , randomize , double blind study include 280 patient . The investigator compare surgical patient standardize RSI procedure intubation condition rocuronium 0.6 mg kg-1 pre-treatment intravenous MgSO4 60 mg kg-1 ( experimental intervention ) succinylcholine 1 mg kg-1 ( control intervention ) . Intubation condition evaluate intubate anaesthesiologist follow predefined criterion . The intubate anesthetist present study drug administration guarantee blind . Only two intubate anaesthetist identify per participate centre . Rapid sequence intubation cornerstone daily anaesthetic practice succinylcholine still frequently use neuromuscular agent context . In patient , succinylcholine contraindicate therefore alternative fast react neuromuscular blocker need . If investigator show investigator propose magnesium-rocuronium regimen provide good intubation condition succinylcholine , investigator study likely important impact daily clinical practice .</detailed_description>
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Rocuronium</mesh_term>
	<mesh_term>Succinylcholine</mesh_term>
	<criteria>Adult , age ≥18 65 year , male female . American Society Anaesthesiology [ ASA ] status I II . Patient able read understand information sheet sign date consent form . Patient schedule elective surgery last ≥60 minute . If patient female childbearing potential , must negative pregnancy test . A history allergy hypersensitivity rocuronium , succinylcholine magnesium sulphate Neuromuscular disease History malignant hyperthermia Preoperative medication know influence neuromuscular function ( instance , certain antibiotic [ aminoglycosides ] , anticonvulsants [ phenytoine ] , IV lidocaine ) Electrolyte abnormalities* ( instance , hypermagnesemia hyperkalemia ) Hepatic dysfunction* ( i.e . bilirubin &gt; 1.5 x upper limit normal ( ULN ) , alanine aminotransferase ( ALT ) &gt; 2.5 x ULN , aspartate aminotransferase ( AST ) &gt; 2.5 x ULN ) Renal insufficiency* ( i.e . creatinine &gt; 1.5 x ULN , creatinine clearance &lt; 60 ml min1 1.73 m2 , estimate formula CockcroftGault ) ) . Atrioventricular heart block Patients magnesium treatment Patients body mass index &lt; 19 &gt; 28 kg m2 Pregnant breastfeed woman Expected difficult intubation mask ventilation . Patient participate clinical trial within 30 day , inclusive , sign informed consent form current trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>rocuronium</keyword>
	<keyword>succinylcholine</keyword>
	<keyword>magnesiumsulphate</keyword>
	<keyword>intubation condition</keyword>
</DOC>